Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Tenapanor Hydrochloride bulk supplier for pharma manufacturers

Tenapanor Hydrochloride 30mg, 50mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 30mg, 50mg

Reference Brands: Ibsrela(USA), Xphozah(USA)

Category: Gastrointestinal Drugs

Tenapanor is a minimally absorbed small-molecule inhibitor of the sodium/hydrogen exchanger NHE3 in the intestines. It works by reducing sodium absorption and increasing intestinal fluid, helping relieve constipation in IBS-C. In patients with chronic kidney disease on dialysis, it helps reduce phosphate absorption from the gut, lowering serum phosphorus levels. The drug is taken orally and remains mostly within the gastrointestinal tract.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Tenapanor Hydrochloride — third party manufacturing & bulk supply

Tenapanor Hydrochloride 30mg, 50mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tenapanor Hydrochloride is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tenapanor Hydrochloride listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tenapanor Hydrochloride →
Back to Listing

Frequently Asked Questions

Tenapanor hydrochloride is used to treat irritable bowel syndrome with constipation (IBS-C) in adults. It works by reducing sodium absorption in the intestines, increasing water in the stool, and improving bowel movements while helping reduce abdominal discomfort.

Tenapanor hydrochloride is a small-molecule sodium/hydrogen exchanger 3 (NHE3) inhibitor. It is formulated from the hydrochloride salt of tenapanor, which acts locally in the gastrointestinal tract without significant systemic absorption.

The primary trade name is Ibsrela.

It is developed and manufactured by Ardelyx, with additional production and distribution partners depending on the region.

The generic name is tenapanor hydrochloride.

The brand name is Ibsrela.

It is manufactured in the USA and other partnered production sites for global distribution.

Related Products

Hyoscyamine Sulfate

Strength:
0.125 mg, 0.375 mg,

Form: Tablets, Capsules, Oral Solution

Reference Brands: Donnatal (USA), Levsin(USA)

View Details
Vibegron

Strength:
75 mg

Form: Tablets

Reference Brands: Gemtesa (USA), Obgemsa (EU/UK)

View Details
Teduglutide

Strength:
5 mg vial

Form: Injection

Reference Brands: Gattex (USA), Revestive (EU/UK)

View Details
Elafibranor

Strength:
80 mg

Form: Tablets

Reference Brands: Iqirvo (USA/EU)

View Details
Magnesium Trisilicate Tablets

Strength:
500mg

Form: Tablets

Reference Brands:

View Details
Simethicone With Dill Oil Solution 1%W/V+0.5% V/V

Strength:
1%w/v + 0.5% v/v

Form: Solution

Reference Brands:

View Details
Magnesium Trisilicate

Strength:
3.33%

Form: Syrup

Reference Brands:

View Details
Magnesium Carbonate+Magnesium Trisilicate+Sodium Bicarbontate Syrup

Strength:
250mg+250mg+250mg

Form: Syrup

Reference Brands:

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.